Clinical Trial Update: Phase II Study of Ixabepilone in Metastatic Breast Cancer and Its Effects on the Ultrastructure of Neurons [Phase 2]

View source ↗

Summary

Phase II study evaluating ixabepilone in metastatic breast cancer and its effects on neuronal ultrastructure; the study is completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ixabepilone (ixabepilone)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-07-13